<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.marketbeat.com/feed/</title><link>https://www.marketbeat.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Thu, 02 Oct 2025 17:37:41 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Nike’s Turnaround: If the Shoe Fits, Buy It!</title><link>https://www.marketbeat.com/originals/nikes-turnaround-if-the-shoe-fits-buy-it/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Nike is well-positioned to regain business momentum and create shareholder value. Analysts liked the Q1 report and signaled a rebound in stock prices.</description><pubDate>Thu, 02 Oct 2025 17:16:00 GMT</pubDate></item><item><title>NVIDIA Breaks Out to New Highs: What Comes Next?</title><link>https://www.marketbeat.com/originals/nvidia-breaks-out-to-new-highs-what-comes-next/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>NVIDIA's stock price breakout is bullish for its direction and the S&amp;P 500. Analysts and technical targets align; a 20% upside lies ahead.</description><pubDate>Thu, 02 Oct 2025 16:05:00 GMT</pubDate></item><item><title>Microsoft Stock Hits Stride in 2025—How Much More Can It Run?</title><link>https://www.marketbeat.com/originals/microsoft-stock-hits-stride-in-2025how-much-more-can-it-run/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Microsoft stock is up 23% in 2025, but analysts see more upside ahead as AI and cloud growth fuel its consistent long-term performance</description><pubDate>Thu, 02 Oct 2025 13:01:00 GMT</pubDate></item><item><title>How Berkshire's OxyChem Buy Cements Its Long-Term Strength</title><link>https://www.marketbeat.com/originals/how-berkshires-oxychem-buy-cements-its-long-term-strength/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>Berkshire Hathaway's multi-billion-dollar acquisition of OxyChem signals a strategic deployment of cash into a stable, long-term industrial earnings e...</description><pubDate>Thu, 02 Oct 2025 12:37:00 GMT</pubDate></item><item><title>Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t Worry</title><link>https://www.marketbeat.com/originals/oklo-insiders-sell-oh-no-this-is-why-investors-shouldnt-worry/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>Oklo's insiders sold in Q2 and Q3, but this poses no threat to investors; institutions and analysts offset it, while short-sellers are a bigger risk.</description><pubDate>Thu, 02 Oct 2025 12:28:00 GMT</pubDate></item></channel></rss>